(c) 2024 PillSync.com

Guaifenesin and pseudoephedrine hydrochloride Extended Release (guaifenesin 600 mg pseudoephedrine hydrochloride 60 mg) Dailymed



IMPRINT: WATSON 600     SHAPE: oval
    COLOR: orange

All Imprints

guaifenesin 600 mg pseudoephedrine hydrochloride 60 mg - watson 600 oval orange

guaifenesin and pseudoephedrine hydrochloride extended release (guaifenesin, pseudoephedrine hydrochloride) tablet, extended release - watson 600 oval orange

12 hr guaifenesin 600 mg / pseudoephedrine hydrochloride 60 mg extended release oral tablet - 600 watson oval orange

Go PRO for all pill images

Active Ingredients (in Each Extended-release Tablet)


Guaifenesin 600 mg

Pseudoephedrine HCl 60 mg

Purpose


Expectorant

Nasal Decongestant

Uses

  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
  • temporarily relieves nasal congestion due to:
  • common cold
  • hay fever
  • upper respiratory allergies
  • temporarily restores freer breathing through the nose
  • promotes nasal and/or sinus drainage
  • temporarily relieves sinus congestion and pressure

Warnings


Do Not Use If You Are


now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask A Doctor Before Use If You Have

  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

When Using This Product

  • do not use more than directed

Stop Use And Ask A Doctor If

  • you get nervous, dizzy, or sleepless
  • symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache.

These could be signs of a serious illness.

If Pregnant Or Breast-feeding,


ask a health professional before use.

Keep Out Of Reach Of Children.


In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

  • do not crush, chew, or break tablet
  • take with a full glass of water
  • this product can be administered without regard for timing of meals
  • adults and children 12 years and older: 2 tablets every 12 hours; not more than 4 tablets in 24 hours
  • children under 12 years of age: do not use

Other Information

  • store between 20-25 °C (68-77 °F)
  • do not use if buler unit is broken or torn

Inactive Ingredients


colloidal silicon dioxide, copovidone, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, sodium starch glycolate, stearic acid

Questions Or Comments?


1-800-719-9260

Package Label.principal Display Panel


DRUG: Guaifenesin and pseudoephedrine hydrochloride Extended Release

GENERIC: Guaifenesin, pseudoephedrine hydrochloride

DOSAGE: TABLET, EXTENDED RELEASE

ADMINSTRATION: ORAL

NDC: 70518-0011-0

COLOR: orange

SHAPE: OVAL

SCORE: No score

SIZE: 18 mm

IMPRINT: 600;Watson

PACKAGING: 1 in 1 BLISTER PACK

OUTER PACKAGING: 18 in 1 CARTON

ACTIVE INGREDIENT(S):
  • GUAIFENESIN 600mg in 1
  • PSEUDOEPHEDRINE HYDROCHLORIDE 60mg in 1

INACTIVE INGREDIENT(S):
  • CELLULOSE, MICROCRYSTALLINE
  • MAGNESIUM STEARATE
  • MALTODEXTRIN
  • POVIDONES
  • COPOVIDONE K25-31
  • HYPROMELLOSES
  • SILICON DIOXIDE
  • STEARIC ACID



DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site